1. Home
  2. IDYA vs KALU Comparison

IDYA vs KALU Comparison

Compare IDYA & KALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$38.85

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo Kaiser Aluminum Corporation

KALU

Kaiser Aluminum Corporation

HOLD

Current Price

$151.85

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
KALU
Founded
2015
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.0B
IPO Year
2019
2006

Fundamental Metrics

Financial Performance
Metric
IDYA
KALU
Price
$38.85
$151.85
Analyst Decision
Strong Buy
Hold
Analyst Count
16
3
Target Price
$52.86
$147.33
AVG Volume (30 Days)
599.8K
145.9K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
N/A
1.78%
EPS Growth
61.90
135.89
EPS
N/A
9.43
Revenue
$218,710,000.00
$1,585,900,000.00
Revenue This Year
N/A
$13.37
Revenue Next Year
$201.05
$2.62
P/E Ratio
N/A
$16.01
Revenue Growth
3024.43
N/A
52 Week Low
$25.36
$73.08
52 Week High
$42.68
$199.89

Technical Indicators

Market Signals
Indicator
IDYA
KALU
Relative Strength Index (RSI) 52.15 42.11
Support Level $35.11 $116.89
Resistance Level $40.58 $196.37
Average True Range (ATR) 1.13 5.67
MACD -0.21 -0.54
Stochastic Oscillator 36.51 17.68

Price Performance

Historical Comparison
IDYA
KALU

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About KALU Kaiser Aluminum Corporation

Kaiser Aluminum Corp specializes in the production of semi-fabricated specialty aluminum mill products, such as aluminum plate and sheet, bare and coated coil and extruded and drawn products, for the end market applications: Aero/HS Products; Packaging; GE Products; and Automotive Extrusions. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.

Share on Social Networks: